Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinoma and establishment of nomogram prediction models
Abstract Objective A significant proportion, ranging from 20 to 40%, of individuals with hepatocellular carcinoma (HCC) do not exhibit elevated Alpha-fetoprotein (AFP) levels. This study aimed to evaluate the utility of serum glypican-3 (GPC3) and protein induced by vitamin K absence or antagonist I...
Saved in:
| Main Authors: | Yingying Lin, Yuefei Ma, Yan Chen, Yepei Huang, Jinchuan Lin, Zhenzhou Xiao, Zhaolei Cui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14025-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers
by: Ling Luo, et al.
Published: (2025-07-01) -
Comparison of the diagnostic performance of two PIVKA-II assays using the GALAD and ASAP algorithms for detecting hepatocellular carcinoma in Chinese patients
by: Yao Hu, et al.
Published: (2025-06-01) -
RETRACTED ARTICLE: Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinoma
by: Woo-Ri Shin, et al.
Published: (2022-04-01) -
Normal Glypican-3 Serum Levels Do Not Eliminate the Risk of Hepatocellular Carcinoma
by: Agnieszka Lembas, et al.
Published: (2024-09-01) -
Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody
by: Liu Chen, et al.
Published: (2025-06-01)